Allon Rafael, MD
Cardiac Electrophysiology · Los Gatos
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 35
- 9 carriers
- Office
- 1
Offices
1 location · Golden State Heart and Vascular Associates · 9 clinicians in this group
Hospitals listed: El Camino Health · Good Samaritan Hospital · UCSF Health Stanyan Hospital. That is not proof they admit you there this week.
Plans that list them
35 plans · 9 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Rafael’s office at (650) 695-0955 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
35 of 35 plans
| Advantage Care (HMO) | Align Senior Care | Listed | Oct 1, 2026 |
| Premier Care (HMO I-SNP) | Align Senior Care | Listed | Oct 1, 2026 |
| Senior Care (HMO I-SNP) | Align Senior Care | Listed | Oct 1, 2026 |
| Alignment Health Advantage PPO (PPO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Prime (HMO-POS) | Anthem Blue Cross Partnership Plan | Listed | Oct 3, 2026 |
| Astiva Health C-SNP WOW - NorCal (HMO C-SNP) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Premier Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Savings Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Blue Shield Inspire (HMO) | Blue Shield of California | Listed | Aug 26, 2026 |
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Care Plan (HMO C-SNP) | Central Health Medicare Plan | Listed, may be out of date | Sep 15, 2025 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A140809 · Current
Licensed to practise in California · since 2016 · expires 2027-10-31 · Tel Aviv University, Sackler School of Medicine.
Matched on the licence number without its letter prefix; check the name before relying on it.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
3 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- El Camino HealthMountain View, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of El Camino Health, which runs 2 hospitalsPatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.291, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.393, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
- Good Samaritan HospitalSan Jose, CAAcute Care Hospital · Proprietary · Has an emergency department · Birthing-friendlyPart of HCA Healthcare, which runs 185 hospitals in 19 statesPatients rate it 2 of 5 · 67% would definitely recommend itOverall rating: 2 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.337, Oct 2024 – Sep 2025
- UCSF Health St. Mary'S HospitalSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of CommonSpirit Health, which runs 145 hospitals in 19 statesPatients rate it 2 of 5 · 60% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0, Oct 2024 – Sep 2025
See every measure and the patient survey for El Camino Health
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.291 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.393 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.96 (0.12 to 1.79) · 2,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.76 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.38 (125.03 to 209.73) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 185 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 814 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13 · 842 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 361 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 4,633 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.34) · 11,474 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.1 to 0.45) · 11,626 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.14 (1.39 to 4.9) · 2,814 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2 (0.61 to 3.39) · 1,327 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.8 to 3.43) · 2,641 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.39 (4.18 to 14.6) · 1,287 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.57 (3.47 to 9.68) · 1,308 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.14 (0.71 to 3.57) · 827 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.6 (0.05 to 1.15) · 9,460 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 122 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.993 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.706 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.376 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 218 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.5 · 962 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 3.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -17 · 922 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18.6 · 860 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.7 · 827 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.1 (4.5 to 8.2) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.4 (10.6 to 16.5) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.7 · 237 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (10 to 16.1) · 1,639 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.8 to 1.1) · 1,619 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,535 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Good Samaritan Hospital
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 1 worse of 8 measures. Readmissions: 0 better, 5 the same, 4 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.337 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.75 (0 to 1.67) · 1,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.84 (0.54 to 1.14) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 143.59 (98.7 to 188.49) · 98 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.7 · 45 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 100 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.7 · 270 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.3 · 573 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.6 · 820 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.5 · 482 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.3 · 3,711 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.12 (0 to 0.3) · 8,866 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.2 (0.01 to 0.38) · 9,051 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.65 (0.74 to 4.56) · 1,929 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.8 (0.21 to 3.39) · 670 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.33 (0.88 to 3.78) · 1,836 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.73 (0 to 13.46) · 669 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.58 (3.96 to 11.19) · 654 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.59 (0.13 to 3.04) · 496 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.27 (0 to 0.87) · 7,373 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.1 · 152 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 1.08 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.542 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.484 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.565 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.8 · 327 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 24.2 · 703 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 61.1 · 289 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 36.3 · 665 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 25.4 · 856 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 19 · 978 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.3 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 12.3 · 46 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 21.2 · 135 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.8 (10.1 to 18.6) · 129 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.2 (0.9 to 1.5) · 531 cases | No different | Jan 2024 – Dec 2024 |
What patients said (704 patients answered, 24% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 2 |
| Quietness | 1 |
| Recommend hospital | 3 |
| Room was "always" clean | 66% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 71% |
| Staff "always" explained | 54% |
| Yes, staff "did" give patients this information | 83% |
| Yes, staff "did" give patients information about help after discharge | 81% |
| Doctors "always" explained things so they could understand | 66% |
| Doctors "always" listened carefully | 69% |
| Doctors "always" treated them with courtesy and respect | 78% |
| Patients who gave a rating of "9" or "10" (high) | 63% |
| Staff "always" explained new medications | 68% |
| Nurses "always" explained things so they could understand | 69% |
| Nurses "always" listened carefully | 73% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 38% |
| "YES", patients would definitely recommend the hospital | 67% |
| Staff "always" explained possible side effects | 40% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for UCSF Health St. Mary'S Hospital
Behind the star rating — Deaths: 2 better, 5 the same, 0 worse of 7 measures. Safety: 1 better, 5 the same, 0 worse of 6 measures. Readmissions: 0 better, 9 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.95 (0 to 1.99) · 413 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.96 (0.58 to 1.34) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 146.74 (92.54 to 200.93) · 30 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 7.4 · 35 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 51 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.6 · 220 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 9.3 · 165 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.4 · 102 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.9 · 1,363 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.24 (0.02 to 0.46) · 2,530 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.32 (0.12 to 0.53) · 2,519 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.02 (0.73 to 5.31) · 590 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.63 (0 to 3.35) · 238 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.07 (0.43 to 3.7) · 554 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 12.7 (4.19 to 21.21) · 259 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.67 (1.51 to 9.83) · 203 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.7 (0.19 to 3.2) · 168 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.21 (0 to 0.99) · 2,258 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.2 · 158 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.6 · 61 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.1 · 291 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -3.4 · 251 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 5.5 · 189 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.1 · 213 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (3.7 to 8.5) · 30 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12 (8.3 to 17.1) · 30 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 4.5 · 176 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 61 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.1 (9.6 to 17.8) · 192 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.5) · 113 cases | No different | Jan 2024 – Dec 2024 |
What patients said (587 patients answered, 20% of those asked)
| Cleanliness | 3 |
| Nurse communication | 2 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 4 |
| Overall hospital rating | 2 |
| Quietness | 1 |
| Recommend hospital | 2 |
| Room was "always" clean | 66% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 60% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 76% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 58% |
| Staff "always" explained new medications | 73% |
| Nurses "always" explained things so they could understand | 70% |
| Nurses "always" listened carefully | 72% |
| Nurses "always" treated them with courtesy and respect | 78% |
| "Always" quiet at night | 41% |
| "YES", patients would definitely recommend the hospital | 60% |
| Staff "always" explained possible side effects | 48% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
Original Medicare doctor bills
$300,843
Medicare paid this office $300,843 for 521 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 71 | $55,721 | $763 |
| Long return visit (40+ min) | 132 | $20,939 | $123 |
| Long return visit (40+ min) | 93 | $18,809 | $171 |
| New patient visit (60+ min) | 90 | $18,540 | $206 |
| Insertion of catheters and destruction of tissue to treat abnormal heart rhythm | 60 | $16,886 | $248 |
See all 33 services
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 71 | $55,721 | $763 |
| Long return visit (40+ min) | 132 | $20,939 | $123 |
| Long return visit (40+ min) | 93 | $18,809 | $171 |
| New patient visit (60+ min) | 90 | $18,540 | $206 |
| Insertion of catheters and destruction of tissue to treat abnormal heart rhythm | 60 | $16,886 | $248 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 85 | $12,926 | $152 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 28 | $12,143 | $434 |
| New patient visit (60+ min) | 77 | $11,578 | $150 |
| Insertion of catheters for recording and pacing of left lower heart chamber rhythm and induction of abnormal rhythm | 75 | $10,792 | $138 |
| Insertion of tube in upper and/or lower heart chambers to record and identify origin of abnormal heart rhythm | 43 | $10,052 | $228 |
| Destruction of tissue of upper heart chamber through tube to treat abnormal heart rhythm | 30 | $8,209 | $249 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality of upper chamber of heart causing supraventricular tachycardia (rapid heart rate) | 11 | $7,467 | $679 |
| Repair of left upper heart chamber with implant with review by radiologist | 14 | $7,071 | $471 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 100 | $6,083 | $59 |
| Short return visit (20+ min) | 52 | $4,890 | $87 |
| Ultrasound of heart with probe in esophagus, with report | 42 | $3,825 | $91 |
| External shock to heart to regulate heart beat | 34 | $3,445 | $96 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 18 | $2,996 | $103 |
| Programming of dual lead pacemaker system | 54 | $2,260 | $31 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 32 | $2,034 | $58 |
| Programming of heart rhythm stimulation after drug infusion | 17 | $998 | $59 |
| Ultrasound evaluation of heart blood vessel with review by radiologist | 13 | $794 | $61 |
| Short return visit | 15 | $762 | $51 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 19 | $737 | $20 |
| Ultrasound of heart blood flow, valves and chambers | 42 | $645 | $15 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 25 | $571 | $22 |
| Ultrasonic guidance for blood vessel access | 46 | $544 | $12 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 44 | $442 | $10 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 28 | $419 | $14 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 15 | $415 | $26 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 16 | $395 | $23 |
| Evaluation of cardiac rhythm monitor system | 13 | $272 | $15 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 42 | $112 | $3 |
Procedures Medicare counted
| Pacemaker insertion or repair | 37 | More than 83% of doctors who do this |
Who their Medicare patients are
521 Original Medicare patients in 2024. Average age 79 · Women 46% · Also on Medicaid 15% · Health risk score 1.66. At or below the middle of the specialty; the typical clinical cardiac electrophysiology clinician is at 1.8.
Conditions among them: High blood pressure 75% · Atrial fibrillation 72% · Coronary heart disease 53% · Heart failure 41% · Diabetes 39% · Chronic kidney disease 31% · Stroke 23% · Cancer 19% · Depression 17% · COPD 15% · Dementia 15%.
The office billed $1,023,715, Medicare allowed $378,155 and paid $300,843; for 1,803 services of 75 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 521 | 1,803 | 79 | 1.66 | $1,023,715 | $300,843 |
| 2023 | 513 | 2,003 | 79 | 1.60 | $1,273,336 | $277,188 |
| 2022 | 484 | 1,932 | 79 | 1.58 | $1,104,533 | $239,109 |
| 2021 | 557 | 2,345 | 79 | 1.52 | $1,488,838 | $353,883 |
| 2020 | 531 | 2,430 | 79 | 1.78 | $1,509,228 | $345,903 |
| 2019 | 568 | 2,468 | 79 | 1.84 | $1,229,191 | $266,212 |
| 2018 | 422 | 1,869 | 79 | 2.02 | $952,060 | $202,959 |
| 2017 | 359 | 1,402 | 79 | 1.79 | $874,596 | $188,654 |
| 2016 | 54 | 150 | 79 | 1.61 | $91,648 | $21,009 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 28 services
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 72 | $56,439 | $763 |
| Long return visit (40+ min) | 237 | $41,030 | $121 |
| New patient visit (60+ min) | 163 | $24,576 | $151 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 52 | $22,379 | $430 |
| Insertion of catheters and destruction of tissue to treat abnormal heart rhythm | 60 | $15,795 | $247 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 78 | $11,876 | $148 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality of upper chamber of heart causing supraventricular tachycardia (rapid heart rate) | 16 | $11,336 | $667 |
| Insertion of catheters for recording and pacing of left lower heart chamber rhythm and induction of abnormal rhythm | 79 | $11,248 | $137 |
| Destruction of tissue of upper heart chamber through tube to treat abnormal heart rhythm | 40 | $9,942 | $249 |
| Repair of left upper heart chamber with implant with review by radiologist | 14 | $6,798 | $486 |
| Ultrasound of heart with probe in esophagus, with report | 63 | $5,762 | $87 |
| Insertion of left lower heart electrode for pacemaker or defibrillator | 12 | $4,860 | $374 |
| Removal and replacement of dual lead permanent pacemaker | 16 | $4,785 | $299 |
| Programming of dual lead pacemaker system | 86 | $3,609 | $32 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 58 | $3,374 | $58 |
| External shock to heart to regulate heart beat | 33 | $3,277 | $91 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 30 | $3,219 | $19 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 42 | $2,017 | $21 |
| New patient visit (60+ min) | 11 | $1,996 | $181 |
| Insertion of heart rhythm monitor under skin | 24 | $1,676 | $70 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 12 | $1,527 | $102 |
| Ultrasound evaluation of heart blood vessel with review by radiologist | 23 | $1,484 | $65 |
| Programming of multiple lead implantable defibrillator system | 16 | $1,057 | $53 |
| Ultrasound of heart blood flow, valves and chambers | 63 | $993 | $15 |
| Evaluation of cardiac rhythm monitor system | 35 | $879 | $15 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 72 | $714 | $10 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 17 | $333 | $20 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 63 | $172 | $3 |
2022: 30 services
| Long return visit (40+ min) | 262 | $41,998 | $117 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 39 | $35,828 | $919 |
| New patient visit (60+ min) | 145 | $21,289 | $147 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 43 | $18,895 | $439 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 56 | $9,364 | $164 |
| Insertion of catheters and destruction of tissue to treat abnormal heart rhythm | 32 | $8,180 | $256 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality of upper chamber of heart causing supraventricular tachycardia (rapid heart rate) | 12 | $8,159 | $680 |
| Destruction of tissue of upper heart chamber through tube to treat abnormal heart rhythm | 30 | $7,666 | $256 |
| Ultrasound of heart with probe in esophagus, with report | 64 | $6,348 | $93 |
| Insertion of left lower heart electrode for pacemaker or defibrillator | 15 | $6,161 | $385 |
| Insertion of tube for 3d mapping of electrical impulses to heart muscle | 25 | $6,100 | $244 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 38 | $4,545 | $22 |
| Programming of dual lead pacemaker system | 105 | $4,241 | $31 |
| Removal and replacement of dual lead permanent pacemaker | 13 | $3,794 | $292 |
| Insertion of catheters for recording and pacing of left lower heart chamber rhythm and induction of abnormal rhythm | 25 | $3,543 | $142 |
| Programming of heart rhythm stimulation after drug infusion | 35 | $3,360 | $96 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 50 | $2,996 | $60 |
| Ultrasound evaluation of heart blood vessel with review by radiologist | 31 | $2,610 | $84 |
| External shock to heart to regulate heart beat | 26 | $2,571 | $95 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 52 | $2,516 | $23 |
| Programming of multiple lead implantable defibrillator system | 21 | $1,476 | $51 |
| Insertion of heart rhythm monitor under skin | 21 | $1,455 | $69 |
| Ultrasound of heart blood flow, valves and chambers | 61 | $1,013 | $16 |
| Programming of dual lead implantable defibrillator system | 11 | $897 | $50 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 12 | $711 | $31 |
| Evaluation of cardiac rhythm monitor system | 37 | $705 | $15 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 55 | $573 | $10 |
| Programming of multiple lead pacemaker system | 14 | $554 | $37 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 21 | $470 | $21 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 61 | $176 | $3 |
2021: 33 services
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 67 | $64,228 | $945 |
| Long return visit (40+ min) | 270 | $43,721 | $118 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 63 | $27,844 | $442 |
| New patient visit (60+ min) | 142 | $21,534 | $152 |
| Insertion of tube for 3d mapping of electrical impulses to heart muscle | 74 | $18,705 | $249 |
| Insertion of catheters and destruction of tissue to treat abnormal heart rhythm | 52 | $18,621 | $358 |
| Destruction of tissue of upper heart chamber through tube to treat abnormal heart rhythm | 41 | $15,025 | $358 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 81 | $13,859 | $171 |
| Long return visit (40+ min) | 73 | $12,048 | $165 |
| New patient visit (60+ min) | 56 | $10,539 | $188 |
| Insertion of implantable defibrillator system | 13 | $10,050 | $773 |
| Programming of heart rhythm stimulation after drug infusion | 66 | $8,234 | $125 |
| Ultrasound evaluation of heart blood vessel with review by radiologist | 72 | $7,983 | $109 |
| Insertion of left lower heart electrode for pacemaker or defibrillator | 17 | $7,097 | $394 |
| Programming of dual lead pacemaker system | 127 | $4,906 | $31 |
| Ultrasound of heart with probe in esophagus, with report | 47 | $4,678 | $95 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 24 | $4,330 | $90 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 37 | $4,093 | $23 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 62 | $3,868 | $62 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 64 | $3,431 | $25 |
| Removal and replacement of dual lead permanent pacemaker | 12 | $3,255 | $271 |
| Insertion of catheters for recording and pacing of left lower heart chamber rhythm and induction of abnormal rhythm | 17 | $2,630 | $146 |
| Programming of multiple lead implantable defibrillator system | 28 | $2,203 | $52 |
| External shock to heart to regulate heart beat | 20 | $2,141 | $97 |
| Insertion of heart rhythm monitor under skin | 20 | $1,455 | $73 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 20 | $1,196 | $33 |
| Insertion of catheters for recording and pacing of left upper heart chamber rhythm and induction of abnormal rhythm | 11 | $1,094 | $99 |
| Programming of dual lead implantable defibrillator system | 12 | $867 | $51 |
| Ultrasound of heart blood flow, valves and chambers | 47 | $784 | $16 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 27 | $745 | $24 |
| Evaluation of cardiac rhythm monitor system | 34 | $740 | $16 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 24 | $271 | $11 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 46 | $133 | $3 |
2020: 33 services
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 54 | $53,680 | $959 |
| Long return visit (40+ min) | 283 | $38,085 | $91 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 62 | $26,673 | $430 |
| Drainage of heart sac using imaging guidance | 139 | $23,196 | $145 |
| New patient visit (60+ min) | 140 | $19,874 | $142 |
| Insertion of tube for 3d mapping of electrical impulses to heart muscle | 62 | $16,292 | $255 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 82 | $15,640 | $176 |
| Insertion of catheters and destruction of tissue to treat abnormal heart rhythm | 37 | $13,880 | $365 |
| Destruction of tissue of upper heart chamber through tube to treat abnormal heart rhythm | 34 | $13,140 | $365 |
| Insertion of implantable defibrillator system | 13 | $10,440 | $803 |
| Programming of heart rhythm stimulation after drug infusion | 56 | $7,958 | $137 |
| Ultrasound evaluation of heart blood vessel with review by radiologist | 55 | $7,541 | $130 |
| Programming of dual lead pacemaker system | 146 | $6,965 | $33 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 34 | $6,768 | $91 |
| Removal and replacement of dual lead permanent pacemaker | 20 | $6,266 | $313 |
| Insertion of left lower heart electrode for pacemaker or defibrillator | 14 | $5,632 | $402 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 75 | $5,055 | $65 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 37 | $3,733 | $22 |
| Ultrasound of heart with probe in esophagus, with report | 34 | $3,420 | $98 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 72 | $3,218 | $23 |
| Long return visit (40+ min) | 19 | $2,511 | $114 |
| New patient visit (60+ min) | 13 | $2,404 | $185 |
| External shock to heart to regulate heart beat | 21 | $2,170 | $99 |
| Programming of multiple lead implantable defibrillator system | 20 | $2,051 | $54 |
| Insertion of catheters for recording and pacing of left lower heart chamber rhythm and induction of abnormal rhythm | 13 | $1,943 | $149 |
| Programming of dual lead implantable defibrillator system | 17 | $1,288 | $48 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 16 | $854 | $29 |
| Insertion of heart rhythm monitor under skin | 11 | $645 | $59 |
| Ultrasound of heart blood flow, valves and chambers | 33 | $559 | $16 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 44 | $516 | $11 |
| Evaluation of cardiac rhythm monitor system | 19 | $406 | $16 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 12 | $284 | $24 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 33 | $97 | $3 |
2019: 31 services
| Long return visit (40+ min) | 297 | $44,810 | $93 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 69 | $30,122 | $437 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 32 | $27,576 | $862 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 116 | $20,734 | $170 |
| New patient visit (60+ min) | 103 | $14,559 | $141 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 68 | $12,652 | $85 |
| Insertion of tube for 3d mapping of electrical impulses to heart muscle | 39 | $9,299 | $232 |
| Insertion of implantable defibrillator system | 11 | $8,644 | $720 |
| Destruction of tissue of upper heart chamber through tube to treat abnormal heart rhythm | 22 | $7,452 | $339 |
| Programming of dual lead pacemaker system | 141 | $7,018 | $33 |
| Insertion of catheters and destruction of tissue to treat abnormal heart rhythm | 17 | $5,703 | $335 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 45 | $5,257 | $21 |
| Insertion of left lower heart electrode for pacemaker or defibrillator | 13 | $5,052 | $389 |
| Programming of heart rhythm stimulation after drug infusion | 36 | $4,689 | $127 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 72 | $4,653 | $62 |
| Ultrasound evaluation of heart blood vessel with review by radiologist | 36 | $4,355 | $118 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 86 | $3,659 | $24 |
| New patient visit (60+ min) | 19 | $3,467 | $182 |
| Ultrasound of heart with probe in esophagus, with report | 33 | $3,402 | $94 |
| External shock to heart to regulate heart beat | 23 | $2,595 | $96 |
| Programming of multiple lead implantable defibrillator system | 26 | $2,089 | $55 |
| Insertion of heart rhythm monitor under skin | 25 | $1,734 | $69 |
| Programming of dual lead implantable defibrillator system | 20 | $1,514 | $49 |
| Insertion of catheters for recording and pacing of left upper heart chamber rhythm and induction of abnormal rhythm | 12 | $1,171 | $98 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 19 | $1,141 | $37 |
| Evaluation of cardiac rhythm monitor system | 36 | $952 | $16 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 81 | $890 | $10 |
| Ultrasound of heart blood flow, valves and chambers | 32 | $558 | $16 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 21 | $485 | $23 |
| Ultrasound of heart, follow-up | 12 | $267 | $22 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 33 | $100 | $3 |
2018: 26 services
| Long return visit (40+ min) | 157 | $26,535 | $92 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 111 | $19,121 | $87 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 112 | $18,589 | $166 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 42 | $17,899 | $426 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 17 | $16,325 | $907 |
| New patient visit (60+ min) | 78 | $10,521 | $135 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality of upper chamber of heart causing supraventricular tachycardia (rapid heart rate) | 11 | $7,423 | $675 |
| Insertion of tube for 3d mapping of electrical impulses to heart muscle | 25 | $7,176 | $266 |
| Ultrasound of heart with probe in esophagus, with report | 47 | $5,243 | $92 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 80 | $4,909 | $60 |
| Insertion of catheters and destruction of tissue to treat abnormal heart rhythm | 13 | $4,814 | $344 |
| Programming of dual lead pacemaker system | 91 | $4,263 | $31 |
| Programming of heart rhythm stimulation after drug infusion | 25 | $3,629 | $130 |
| Ultrasound evaluation of heart blood vessel with review by radiologist | 24 | $2,993 | $120 |
| New patient visit (60+ min) | 14 | $2,495 | $178 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 18 | $2,370 | $22 |
| External shock to heart to regulate heart beat | 21 | $2,254 | $94 |
| Long return visit (40+ min) | 16 | $2,142 | $119 |
| Programming of multiple lead implantable defibrillator system | 13 | $1,392 | $54 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 30 | $1,250 | $23 |
| Insertion of catheters for recording and pacing of left upper heart chamber rhythm and induction of abnormal rhythm | 11 | $1,145 | $95 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 38 | $918 | $22 |
| Ultrasound of heart blood flow, valves and chambers | 46 | $870 | $16 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 71 | $791 | $10 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 18 | $435 | $22 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 46 | $151 | $3 |
2017: 29 services
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 22 | $19,647 | $893 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 43 | $18,521 | $431 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 102 | $17,740 | $172 |
| New patient visit (60+ min) | 97 | $13,547 | $140 |
| Long return visit (40+ min) | 87 | $11,799 | $92 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 64 | $10,568 | $89 |
| New patient visit (60+ min) | 53 | $9,331 | $176 |
| Insertion of tube for 3d mapping of electrical impulses to heart muscle | 27 | $8,851 | $316 |
| Insertion of implantable defibrillator system | 11 | $8,351 | $759 |
| Insertion of catheters and destruction of tissue to treat abnormal heart rhythm | 14 | $4,562 | $326 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 79 | $4,446 | $55 |
| Programming of heart rhythm stimulation after drug infusion | 33 | $4,245 | $129 |
| Long return visit (40+ min) | 20 | $3,601 | $129 |
| Destruction of tissue of upper heart chamber through tube to treat abnormal heart rhythm | 11 | $3,498 | $318 |
| Ultrasound evaluation of heart blood vessel with review by radiologist | 26 | $3,133 | $121 |
| Programming of dual lead pacemaker system | 66 | $2,850 | $33 |
| Implantation patient-activated heart monitoring device | 14 | $2,716 | $194 |
| Ultrasound of heart with probe in esophagus, with report | 24 | $2,344 | $94 |
| Return visit (30+ min) | 21 | $1,420 | $65 |
| External shock to heart to regulate heart beat | 14 | $1,407 | $94 |
| Insertion of catheters for recording and pacing of left upper heart chamber rhythm and induction of abnormal rhythm | 12 | $1,173 | $98 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 11 | $1,081 | $23 |
| Programming of dual lead pacemaker system | 18 | $829 | $33 |
| Programming of dual lead implantable defibrillator system | 12 | $801 | $47 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 69 | $725 | $10 |
| Ultrasound of heart blood flow, valves and chambers | 23 | $380 | $16 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 14 | $364 | $24 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 15 | $334 | $22 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 24 | $69 | $3 |
2016: 2 services
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 22 | $3,768 | $171 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 11 | $1,407 | $88 |
Medicaid work
$703 in 2024
Medicaid paid $703 for 125 billed services this clinician did in 2024, up to 72 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 125 | $703 |
| 2024 | 125 | 1 | 72 | $703 |
| 2023 | 99 | 1 | 67 | $337 |
See the largest Medicaid services in earlier years
2023
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 99 | $337 |
Drugs they prescribed that Part D paid
$387,939
Pharmacies billed $387,939 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 1,344) in 2024. At or below the middle of the specialty; the typical clinical cardiac electrophysiology clinician is at 0%.
907 generic and fewer than 11 brand-name prescriptions · $387,939 in drug cost · 59 antibiotic prescriptions to 54 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 270 | $242,827 | $899 |
| Xarelto | 80 | $89,731 | $1,122 |
| Entresto | 21 | $16,532 | $787 |
| Colchicine | 91 | $6,648 | $73 |
| Sotalol | 191 | $2,998 | $16 |
See all 23 drugs
| Eliquis | 270 | $242,827 | $899 |
| Xarelto | 80 | $89,731 | $1,122 |
| Entresto | 21 | $16,532 | $787 |
| Colchicine | 91 | $6,648 | $73 |
| Sotalol | 191 | $2,998 | $16 |
| Flecainide Acetate | 55 | $2,278 | $41 |
| Matzim La | 16 | $2,083 | $130 |
| Diltiazem 24hr Er (Cd) | 43 | $1,821 | $42 |
| Diltiazem 24hr Er | 35 | $1,370 | $39 |
| Propafenone Hcl Er | 11 | $1,276 | $116 |
| Diltiazem 24hr Er (La) | 14 | $972 | $69 |
| Pantoprazole | 92 | $954 | $10 |
| Metoprolol | 63 | $783 | $12 |
| Amiodarone | 24 | $714 | $30 |
| Clopidogrel | 32 | $427 | $13 |
| Sotalol Af | 27 | $411 | $15 |
| Diltiazem 24hr Er (Xr) | 19 | $407 | $21 |
| Metoprolol | 24 | $318 | $13 |
| Carvedilol | 29 | $289 | $10 |
| Cephalexin | 46 | $216 | $5 |
| Digoxin | 13 | $162 | $12 |
| Losartan | 14 | $138 | $10 |
| Furosemide | 13 | $59 | $5 |
Year by year
| 2024 | 1,344 | 339 | 0% (0) | None | $387,939 |
| 2023 | 1,398 | 340 | None | 34% | $446,843 |
| 2022 | 1,525 | 293 | 0% (0) | None | $453,145 |
| 2021 | 1,562 | 303 | 0% (0) | 33% | $371,727 |
| 2020 | 1,579 | 297 | None | 34% | $354,921 |
| 2019 | 1,336 | 243 | None | 33% | $294,419 |
| 2018 | 622 | 139 | 0% (0) | 24% | $119,713 |
| 2017 | 324 | 105 | 0% (0) | 38% | $63,522 |
| 2016 | 105 | 32 | 0% (0) | 60% | $28,938 |
| 2015 | 75 | 33 | 0% (0) | 37% | $12,968 |
| 2014 | 103 | 35 | 0% (0) | 17% | $9,469 |
| 2013 | 163 | 23 | 0% (0) | 17% | $4,588 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 21 drugs
| Eliquis | 286 | $252,959 | $884 |
| Xarelto | 104 | $113,752 | $1,094 |
| Entresto | 24 | $31,928 | $1,330 |
| Diltiazem 24hr Er (Cd) | 65 | $5,077 | $78 |
| Sotalol | 147 | $4,346 | $30 |
| Propafenone Hcl Er | 26 | $4,101 | $158 |
| Colchicine | 59 | $4,097 | $69 |
| Flecainide Acetate | 51 | $3,652 | $72 |
| Diltiazem 24hr Er | 48 | $2,462 | $51 |
| Amiodarone | 45 | $2,094 | $47 |
| Metoprolol | 83 | $1,500 | $18 |
| Sotalol Af | 16 | $1,077 | $67 |
| Pantoprazole | 48 | $646 | $13 |
| Diltiazem 24hr Er (Xr) | 21 | $544 | $26 |
| Clopidogrel | 28 | $505 | $18 |
| Carvedilol | 32 | $377 | $12 |
| Metoprolol | 30 | $371 | $12 |
| Cephalexin | 61 | $249 | $4 |
| Atorvastatin | 18 | $220 | $12 |
| Losartan | 21 | $195 | $9 |
| Furosemide | 31 | $176 | $6 |
2022: 24 drugs
| Eliquis | 309 | $249,653 | $808 |
| Xarelto | 100 | $104,617 | $1,046 |
| Entresto | 47 | $48,622 | $1,035 |
| Diltiazem 24hr Er (Cd) | 88 | $7,804 | $89 |
| Propafenone Hcl Er | 25 | $7,029 | $281 |
| Flecainide Acetate | 88 | $5,530 | $63 |
| Sotalol | 121 | $3,313 | $27 |
| Metoprolol | 149 | $2,707 | $18 |
| Mexiletine | 11 | $2,026 | $184 |
| Diltiazem 24hr Er | 38 | $1,861 | $49 |
| Amiodarone | 68 | $1,492 | $22 |
| Sotalol Af | 28 | $1,228 | $44 |
| Spironolactone | 29 | $404 | $14 |
| Isosorbide Mononitrate Er | 16 | $297 | $19 |
| Metoprolol | 22 | $267 | $12 |
| Atorvastatin | 21 | $230 | $11 |
| Carvedilol | 28 | $221 | $8 |
| Cephalexin | 55 | $205 | $4 |
| Pantoprazole | 14 | $205 | $15 |
| Clopidogrel | 23 | $200 | $9 |
| Furosemide | 39 | $199 | $5 |
| Dilt-Xr | 11 | $179 | $16 |
| Bumetanide | 11 | $159 | $14 |
| Losartan | 34 | $152 | $4 |
2021: 27 drugs
| Eliquis | 277 | $204,021 | $737 |
| Xarelto | 106 | $83,304 | $786 |
| Entresto | 51 | $36,224 | $710 |
| Diltiazem 24hr Er (Cd) | 91 | $8,140 | $89 |
| Propafenone Hcl Er | 11 | $6,312 | $574 |
| Colchicine | 30 | $4,561 | $152 |
| Flecainide Acetate | 77 | $4,223 | $55 |
| Metoprolol | 138 | $2,953 | $21 |
| Sotalol | 115 | $2,861 | $25 |
| Diltiazem 24hr Er | 45 | $2,093 | $47 |
| Amiodarone | 50 | $1,775 | $36 |
| Cartia Xt | 15 | $925 | $62 |
| Potassium Chloride | 18 | $492 | $27 |
| Furosemide | 60 | $417 | $7 |
| Pantoprazole | 38 | $413 | $11 |
| Spironolactone | 35 | $378 | $11 |
| Dilt-Xr | 11 | $268 | $24 |
| Bumetanide | 14 | $262 | $19 |
| Cephalexin | 76 | $253 | $3 |
| Metoprolol | 30 | $222 | $7 |
| Atorvastatin | 23 | $203 | $9 |
| Lisinopril | 15 | $162 | $11 |
| Losartan | 36 | $154 | $4 |
| Hydrochlorothiazide | 18 | $119 | $7 |
| Pacerone | 12 | $109 | $9 |
| Carvedilol | 20 | $92 | $5 |
| Sulfamethoxazole-Trimethoprim | 12 | $37 | $3 |
2020: 26 drugs
| Eliquis | 338 | $218,197 | $646 |
| Xarelto | 65 | $45,823 | $705 |
| Entresto | 58 | $34,813 | $600 |
| Propafenone Hcl Er | 32 | $14,435 | $451 |
| Diltiazem 24hr Er (Cd) | 83 | $8,684 | $105 |
| Flecainide Acetate | 90 | $5,974 | $66 |
| Metoprolol | 132 | $3,384 | $26 |
| Sotalol | 105 | $2,239 | $21 |
| Amiodarone | 64 | $1,111 | $17 |
| Sotalol Af | 17 | $972 | $57 |
| Diltiazem 24hr Er | 20 | $800 | $40 |
| Digoxin | 12 | $792 | $66 |
| Cartia Xt | 34 | $790 | $23 |
| Pantoprazole | 43 | $632 | $15 |
| Warfarin | 20 | $438 | $22 |
| Carvedilol | 30 | $223 | $7 |
| Bumetanide | 12 | $220 | $18 |
| Furosemide | 46 | $216 | $5 |
| Cephalexin | 65 | $210 | $3 |
| Metoprolol | 44 | $201 | $5 |
| Atorvastatin | 21 | $185 | $9 |
| Clopidogrel | 12 | $171 | $14 |
| Lisinopril | 14 | $140 | $10 |
| Ibuprofen | 12 | $97 | $8 |
| Spironolactone | 17 | $91 | $5 |
| Amlodipine Besylate | 14 | $84 | $6 |
2019: 25 drugs
| Eliquis | 306 | $185,273 | $605 |
| Xarelto | 59 | $44,410 | $753 |
| Entresto | 37 | $18,760 | $507 |
| Propafenone Hcl Er | 28 | $15,582 | $557 |
| Diltiazem 24hr Er (Cd) | 45 | $5,067 | $113 |
| Flecainide Acetate | 98 | $4,508 | $46 |
| Metoprolol | 94 | $2,224 | $24 |
| Sotalol | 56 | $1,812 | $32 |
| Sotalol Af | 37 | $1,527 | $41 |
| Digoxin | 11 | $622 | $57 |
| Diltiazem 24hr Er | 13 | $617 | $47 |
| Pantoprazole | 35 | $545 | $16 |
| Metoprolol | 76 | $451 | $6 |
| Atorvastatin | 19 | $393 | $21 |
| Carvedilol | 33 | $282 | $9 |
| Clopidogrel | 23 | $279 | $12 |
| Amiodarone | 19 | $274 | $14 |
| Lisinopril | 45 | $268 | $6 |
| Furosemide | 33 | $195 | $6 |
| Cephalexin | 49 | $180 | $4 |
| Warfarin | 11 | $155 | $14 |
| Spironolactone | 28 | $123 | $4 |
| Amlodipine Besylate | 19 | $97 | $5 |
| Hydrochlorothiazide | 14 | $92 | $7 |
| Losartan | 13 | $76 | $6 |
2018: 13 drugs
| Eliquis | 86 | $61,103 | $711 |
| Xarelto | 36 | $32,486 | $902 |
| Propafenone Hcl Er | 16 | $8,537 | $534 |
| Flecainide Acetate | 74 | $5,011 | $68 |
| Amiodarone | 35 | $1,248 | $36 |
| Diltiazem 24hr Er (Cd) | 30 | $1,156 | $39 |
| Sotalol | 27 | $687 | $25 |
| Metoprolol | 38 | $526 | $14 |
| Clopidogrel | 37 | $465 | $13 |
| Metoprolol | 36 | $152 | $4 |
| Losartan | 16 | $127 | $8 |
| Cephalexin | 28 | $102 | $4 |
| Lisinopril | 37 | $95 | $3 |
2017: 8 drugs
| Eliquis | 61 | $34,282 | $562 |
| Xarelto | 40 | $20,706 | $518 |
| Flecainide Acetate | 36 | $1,320 | $37 |
| Diltiazem 24hr Er | 23 | $514 | $22 |
| Amiodarone | 13 | $253 | $19 |
| Cephalexin | 30 | $134 | $4 |
| Metoprolol | 28 | $83 | $3 |
| Sulfamethoxazole-Trimethoprim | 18 | $60 | $3 |
2016: 3 drugs
| Eliquis | 29 | $15,617 | $539 |
| Xarelto | 18 | $11,080 | $616 |
| Metoprolol | 20 | $636 | $32 |
2015: 1 drug
| Eliquis | 14 | $5,245 | $375 |
2014: 1 drug
| Isosorbide Mononitrate Er | 11 | $1,079 | $98 |
2013: 6 drugs
| Metoprolol | 21 | $949 | $45 |
| Simvastatin | 26 | $240 | $9 |
| Amlodipine Besylate | 11 | $208 | $19 |
| Metoprolol | 24 | $51 | $2 |
| Lisinopril | 22 | $42 | $2 |
| Hydrochlorothiazide | 21 | $27 | $1 |
Money from drug and device companies
$4,663 in 2025
| 2025 | 7 | 43 | $1,200 | $4,663 |
| 2024 | 6 | 11 | None | $375 |
| 2023 | 6 | 22 | None | $902 |
| 2022 | 10 | 41 | None | $1,404 |
| 2021 | 10 | 82 | None | $2,791 |
| 2020 | 10 | 52 | None | $1,486 |
| 2019 | 9 | 66 | $200 | $4,444 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Medtronic | Evera Mri Xt Dr Surescan | $2,230 | 14 payments
|
| Biotronik | Amvia Edge | $1,890 | 10 payments
|
| Abbott Laboratories | Perclose Prostyle | $235 | 11 payments
|
| Biosense Webster | Carto 3 | $191 | 4 payments
|
| Cardiva Medical | Cardiva Vascade Mvp Vvcs 6-12f | $63 | 2 payments
|
| Boston Scientific | Watchman | $39 | 1 payment
|
See all 43 published payments
| Biotronik | Meals · 2025-11-25 | Amvia Edge | $16 |
| Biotronik | Meals · 2025-11-19 | Amvia Edge | $143 |
| Medtronic | Meals · 2025-11-14 | Affera Mapping System | $9 |
| Biosense Webster | Meals · 2025-11-13 | Carto 3 | $140 |
| Abbott Laboratories | Meals · 2025-11-11 | Amplatzer Amulet | $14 |
| Cardiva Medical | Meals · 2025-11-07 | Cardiva Vascade Mvp Xl Vvcs 10-12f | $29 |
| Biosense Webster | Meals · 2025-11-05 | Nuvision Ice Catheter | $28 |
| Abbott Laboratories | Meals · 2025-10-22 | Ensite | $21 |
| Boston Scientific | Meals · 2025-09-19 | Watchman | $39 |
| Biosense Webster | Meals · 2025-09-17 | Nuvision Ice Catheter | $2 |
| Abbott Laboratories | Meals · 2025-09-17 | Perclose Proglide | $15 |
| Medtronic | Meals · 2025-09-12 | Aquamantys(Tm) | $26 |
| Abbott Laboratories | Meals · 2025-08-25 | Perclose Prostyle | $31 |
| Medtronic | Meals · 2025-08-22 | Affera Mapping System | $37 |
| Abbott Laboratories | Meals · 2025-08-01 | Agilis | $25 |
| Medtronic | Meals · 2025-06-11 | Affera Mapping System | $144 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Meals · 2025-05-28 | Lifevest | $15 |
| Medtronic | Travel · 2025-05-21 | Evera Mri Xt Dr Surescan | $137 |
| Medtronic | Meals · 2025-05-19 | Evera Mri Xt Dr Surescan | $60 |
| Medtronic | Meals · 2025-05-19 | Evera Mri Xt Dr Surescan | $27 |
| Medtronic | Travel · 2025-05-17 | Aurora Ev-Icd Mri Surescan | $184 |
| Medtronic | Travel · 2025-05-16 | Evera Mri Xt Dr Surescan | $601 |
| Medtronic | Travel · 2025-05-16 | Evera Mri Xt Dr Surescan | $500 |
| Medtronic | Travel · 2025-05-16 | Evera Mri Xt Dr Surescan | $249 |
| Medtronic | Travel · 2025-05-16 | Evera Mri Xt Dr Surescan | $29 |
| Medtronic | Meals · 2025-05-16 | Aurora Ev-Icd Mri Surescan | $58 |
| Abbott Laboratories | Meals · 2025-05-07 | Perclose Prostyle | $25 |
| Biotronik | Meals · 2025-04-26 | None | $101 |
| Biotronik | Meals · 2025-04-25 | None | $122 |
| Abbott Laboratories | Meals · 2025-04-21 | Perclose Proglide | $24 |
| Abbott Laboratories | Meals · 2025-04-04 | Perclose Prostyle | $30 |
| Abbott Laboratories | Meals · 2025-04-02 | Perclose Prostyle | $21 |
| Abbott Laboratories | Meals · 2025-04-01 | Amplatzer | $6 |
| Abbott Laboratories | Meals · 2025-03-29 | Amplatzer | $24 |
| Medtronic | Meals · 2025-03-27 | Aurora Ev-Icd Mri Surescan | $170 |
| Biosense Webster | Meals · 2025-03-04 | Carto 3 | $22 |
| Biotronik | Paid to speak or teach · 2025-02-19 | None | $1,200 |
| Cardiva Medical | Meals · 2025-02-17 | Cardiva Vascade Mvp Vvcs 6-12f | $35 |
| Biotronik | Meals · 2025-01-18 | Amvia Edge | $14 |
| Biotronik | Meals · 2025-01-11 | None | $43 |
| Biotronik | Meals · 2025-01-11 | None | $97 |
| Biotronik | Meals · 2025-01-11 | None | $128 |
| Biotronik | Meals · 2025-01-11 | None | $26 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $375
| Biosense Webster | Carto 3 | $187 | 3 payments
|
| Abbott Laboratories | Diamondback Coronary | $72 | 4 payments
|
| Inari Medical | Flowtriever Catheter, S | $42 | 1 payment
|
| Mylan Specialty L.P. | Yupelri | $29 | 1 payment
|
| Boston Scientific | Watchman Flx | $23 | 1 payment
|
| Medtronic | Mycarelink | $22 | 1 payment
|
2023: $902
| Biotronik | Acticor 7 Vr-T Dx | $359 | 5 payments
|
| Boston Scientific | Watchman Flx | $201 | 3 payments
|
| Biosense Webster | Carto 3 | $139 | 2 payments
|
| Abbott Laboratories | Jot Dx | $137 | 10 payments
|
| Terumo Medical | Angio-Seal | $36 | 1 payment
|
| Mylan Specialty L.P. | Yupelri | $30 | 1 payment
|
2022: $1,404
| Abbott Laboratories | Confirm Rx | $382 | 17 payments
|
| Biosense Webster | Carto 3 | $379 | 5 payments
|
| Biotronik | Biomonitor | $270 | 8 payments
|
| Boston Scientific | Watchman Access System | $180 | 2 payments
|
| Genzyme | Dupixent | $57 | 3 payments
|
| Actelion Pharmaceuticals US | Opsumit | $53 | 2 payments
|
| Novartis Pharmaceuticals | Xolair | $25 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | Stiolto Respimat | $24 | 1 payment
|
| Merck Sharp & Dohme | None | $18 | 1 payment
|
| Bayer HealthCare Pharmaceuticals | Adempas | $17 | 1 payment
|
2021: $2,791
| Abbott Laboratories | Assurity Pacemaker | $1,079 | 48 payments
|
| Medtronic | Micra | $728 | 11 payments
|
| Boston Scientific | General Ep | $298 | 3 payments
|
| Biotronik | Edora | $282 | 5 payments
|
| GlaxoSmithKline | Nucala | $139 | 7 payments
|
| Biosense Webster | Carto 3 | $123 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | Stiolto Respimat | $59 | 3 payments
|
| Actelion Pharmaceuticals US | Opsumit | $50 | 2 payments
|
| Bardy Diagnostics | Carnation Ambulatory Monitor | $17 | 1 payment
|
| Bayer HealthCare Pharmaceuticals | Adempas | $16 | 1 payment
|
2020: $1,486
| Medtronic Vascular | Micra | $346 | 7 payments
|
| Biotronik | None | $310 | 5 payments
|
| Boston Scientific | Sq-Rx Pulse Generator | $232 | 6 payments
|
| Abbott Laboratories | Quadra Assura Crt Defibrillator | $202 | 20 payments
|
| Janssen Pharmaceuticals | Xarelto | $125 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | Ofev | $92 | 4 payments
|
| GlaxoSmithKline | Anoro Ellipta | $64 | 3 payments
|
| Bayer HealthCare Pharmaceuticals | Adempas | $48 | 3 payments
|
| Mylan Specialty L.P. | Yupelri | $40 | 2 payments
|
| Actelion Pharmaceuticals US | Opsumit | $29 | 1 payment
|
2019: $4,444
| Medtronic Vascular | Arctic Front | $2,112 | 17 payments
|
| Biosense Webster | Carto 3 System | $867 | 9 payments
|
| Biotronik | None | $661 | 7 payments
|
| Abbott Laboratories | Allure Quadra Rf Crt Pacemaker | $448 | 24 payments
|
| Boston Scientific | Rhythmia | $239 | 4 payments
|
| Janssen Pharmaceuticals | Xarelto | $36 | 2 payments
|
| Stryker | Tritanium | $34 | 1 payment
|
| Philips Electronics North America | Glidelight | $30 | 1 payment
|
| E.R. Squibb & Sons L.L.C. | Eliquis | $18 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 51.2 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1851553671
- Licence
- CA 140809California A140809: Current · expires 2027-10-31
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RC0001X (207RC0001X)
- Mailing address
- 1850 El Camino Real Ste 200, Burlingame, CA, 94010
- NPI first listed
- 2008-07-02
- NPI last updated
- 2024-07-30
- NPI record certified
- 2024-07-30
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 1850 El Camino Real Ste 200, Burlingame, CA, 94010